- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02279030
Use of MIBG Scan Images in PVC Ablations (PVC-MIBG)
Three Dimensional Neuro-cardiac Imaging Using 123I-metaiodobenzylguanidine Single Photon Emission Computed Tomography to Guide Premature Ventricular Contractions Ablations
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Premature ventricular contractions (PVC) are the most common arrhythmia to be observed in the absence of structural heart disease, and 'frequent' PVCs are estimated to occur in 1-4% of the general population.1 Idiopathic PVCs are usually associated with a benign course from the standpoint of arrhythmic death, but often result in significant symptoms for the patient such as palpitations, dizziness, pre-syncope and rarely syncope. More recently, a new concept of PVC- mediated cardiomyopathy has emerged that is reversible with suppression of the PVCs.2 Both of those patient populations are currently targeted with PVC suppressive therapy which often involves as the first step using medical therapy such as a beta blocker, calcium channel blocker or an antiarrhythmic. If those fail or if the patients wants to avoid medical therapy an ablation to eliminate the abnormal myocardial tissue that is the origin of the PVCs is often performed.
Radiofrequency ablation (RFA) for PVCs has been performed for several decades and has a well-defined safety and effectiveness profile in patients with symptomatic frequent ventricular ectopic beats and PVC-induced cardiomyopathy. Successful PVC suppression ≥80% of RV and LV PVCs has been reported to be as high as ~80% using an ablation approach.9 Studies found improvements in patient symptoms with elimination of PVCs. In LV dysfunction following ablation demonstrated a significant inverse correlation between EF and PVC burden before ablation, and a significant post procedural improvement in ejection fraction (EF) in 82% of patients who had abnormal systolic function before ablation.8 Improvement of the overall LV EF ranged from 13%-23% after PVC ablation.5,8,10
Autonomic innervation of the heart plays a major role in the normal regulation of myocardial function, heart rate, and coronary blood flow. Abnormal sympathetic cardiac innervation has been shown to have prognostic value for different heart diseases, e.g. heart transplant, coronary artery disease, heart failure, arrhythmias, etc. Importantly, there is a clear association with an increased cardiac morbidity and mortality in heart diseases. Patients with myocardial infarction as well as patients with heart failure exhibit well recognized abnormalities in autonomic tone. PVCs especially in the setting of preserved EF (normal heart patients) have frequently an automatic/triggered mechanism, which is influenced by the cardiac innervation.
Decreased reuptake by impaired myocardial presynaptic nerve terminals results in a buildup of these catecholamines in the synaptic cleft. This leads to a downregulation of postsynaptic beta-adrenergic receptors, with resultant worsening cardiomyopathy and increased arrhythmogenesis.
Cardiac sympathetic innervation can be directly imaged with commonly used nuclear radioisotope, 123I-meta-iodobenzylguanidine (123I-mIBG). As a norepinephrine analogue, 123I-mIBG is similarly released into the synaptic cleft in response to sympathetic input by presynaptic nerve terminals 123I-metaiodobenzylguanidine (123I-MIBG) allows visualization of the cardiac innervation, which could provide additional information to understand the origin, prognosis and pathophysiology of PVCs and guide potential ablation procedures.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Scheduled for PVC ablation
Exclusion Criteria:
- pregnancy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Utilization of MIBG imaging for PVC ablations
Time Frame: 2 years
|
To determine if MIBG imaging provides decreased PVC ablation time
|
2 years
|
Decrease PVC occurrence
Time Frame: 2 years
|
Does MIBG imaging allow for treatment that provides improved outcomes in decreasing PVCs
|
2 years
|
Increase in Motility
Time Frame: 2 years
|
Do MIBG follow-ups demonstrate an improvement in cardiac motility
|
2 years
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HP-00062156
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Ventricular Contractions
-
Hunter Holmes Mcguire Veteran Affairs Medical CenterWashington University School of Medicine; National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingCardiomyopathies | Ventricular Premature Beats, Contractions, or SystolesUnited States, Canada
-
University of California, San FranciscoCompletedPremature Atrial Contractions | Premature Ventricular ContractionsUnited States
-
University of California, San FranciscoRecruitingPremature Ventricular Contraction | Premature Atrial ComplexUnited States
-
StereotaxisCompletedVentricular Tachycardia | Premature Ventricular ContractionNetherlands, Czechia
-
Catheter Precision. Inc.Not yet recruitingVentricular Tachycardia | Ventricular Arrythmia | Premature Ventricular Contraction
-
Mayo ClinicWithdrawnVentricular Tachycardia | Premature Ventricular ContractionUnited States
-
Catheter Precision. Inc.Completed
-
C. R. BardTerminatedBundle-Branch Block | Tachycardia | Atrioventricular Block | Atrial Flutter | Premature Ventricular Contraction | Premature Atrial Contraction | Indication for Peripheral Intravenous Catheterization | Premature Junctional ContractionUnited States, Australia
-
University of California, Los AngelesEnrolling by invitationVentricular Tachycardia | Cardiomyopathy | Ventricular Arrhythmia | Premature Ventricular Contraction (PVC)United States, Netherlands, Israel, Italy, Canada, Japan, Spain, United Kingdom
-
Kansas City Heart Rhythm Research FoundationKansas City Heart Rhythm InstituteNot yet recruitingMyocarditis | Ventricular Tachycardia (VT) | Premature Ventricular ContractionsUnited States
Clinical Trials on MIBG nuclear scan
-
Nuclear Medicine Consultants, Inc.Unknown
-
Singapore General HospitalNational Heart Centre Singapore; National Medical Research Council (NMRC),...Completed
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Completed
-
Indiana UniversityJerome A. Josephs Fund for Transplant Innovation FundRecruitingSimultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates (RECOVERY)TransplantUnited States
-
The Affiliated Hospital Of Guizhou Medical UniversityActive, not recruitingIntracerebral HemorrhageChina
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy SubjectUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingThymoma | Recurrent Malignant ThymomaUnited States
-
GE HealthcareCompletedCongestive Heart FailureUnited States